QT
CYTK icon

Quantbot Technologies’s Cytokinetics CYTK Stock Holding History

Quantbot Technologies’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
+2,991
New +$215K 0.01% 1184
2024
Q2 		– Sell
-1,593
Closed -$112K – 1537
2024
Q1 		$112K Buy
+1,593
New +$123K 0.01% 1144
2022
Q2 		– Sell
-1,568
Closed -$57K – 1775
2022
Q1 		$57K Sell
1,568
-12,180
-89% -$433K 0.01% 1170
2021
Q4 		$626K Sell
13,748
-8,288
-38% -$320K 0.05% 474
2021
Q3 		$787K Buy
+22,036
New +$649K 0.06% 459
2021
Q2 		– Sell
-1,900
Closed -$44K – 1524
2021
Q1 		$44K Buy
+1,900
New +$40.6K ﹤0.01% 1036
2020
Q4 		– Sell
-1,600
Closed -$34K – 1366
2020
Q3 		$34K Buy
1,600
+1,100
+220% +$25.7K ﹤0.01% 921
2020
Q2 		$11K Buy
+500
New +$9.38K ﹤0.01% 912
2019
Q3 		– Sell
-700
Closed -$7K – 1327
2019
Q2 		$7K Buy
+700
New +$6.75K ﹤0.01% 1110
2018
Q1 		– Sell
-2,577
Closed -$21K – 1263
2017
Q4 		$21K Buy
+2,577
New +$29.3K ﹤0.01% 1065
2017
Q3 		– Sell
-4,708
Closed -$56K – 1236
2017
Q2 		$56K Buy
+4,708
New +$65.4K 0.01% 892
2016
Q1 		– Sell
-9,419
Closed -$98K – 1191
2015
Q4 		$98K Buy
+9,419
New +$92.4K 0.02% 653

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantbot Technologies's CYTK Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Cytokinetics (CYTK) in Q2 2026: 2,991 shares worth $255K. The stake represents 0.01% of the portfolio and ranks #1184 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in CYTK as recently as Q1 2024.

Quantbot Technologies first reported a position in CYTK in Q4 2015 and has held it in 12 quarters since. The position peaked at $787K in Q3 2021. 483 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Quantbot Technologies held 2,991 shares of Cytokinetics worth $255K as of Q2 2026.
  • Cytokinetics was a new Quantbot Technologies position in Q2 2026.
  • Cytokinetics made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1184 holding.
  • Quantbot Technologies first reported a position in Cytokinetics in Q4 2015 and has held it in 12 quarters since.
  • Quantbot Technologies's Cytokinetics position peaked at $787K in Q3 2021.
  • 483 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.